CR Construction (01582) announced its interim results, with a net profit attributable to shareholders of HKD 24.27 million, representing a year-on-year decrease of 32.27%.
(01582) released its interim results for the six months ended 30 June 2025, during which the group achieved revenue...
CR Construction (01582) released its mid-year performance for the six months ended June 30, 2025. The group achieved a profit of HK$3.571 billion, an increase of 28.76% year-on-year; the net profit attributable to owners of the company was HK$24.278 million, a decrease of 32.27% year-on-year; and the basic earnings per share was 4.86 HK cents.
The announcement stated that revenue from building construction projects increased from approximately HK$2.414 billion in the six months ended June 30, 2024, to approximately HK$3.142 billion in the six months ended June 30, 2025, an increase of approximately HK$728 million or approximately 30.1%. The increase in revenue was driven by the additional income brought in by new projects and existing projects during the reporting period.
Related Articles

US Stock Market Move | "The most important stock on earth" NVIDIA Corporation (NVDA.US) is about to announce its second quarter earnings. The stock price rose nearly 1% in intraday trading.

US Stock Market Move | Chip stocks rose slightly, with AMD (AMD.US) up more than 1.3%.

US Stock Market Move | Femasys (FEMY.US) stock price plummets 37%, hitting a new low for the year.
US Stock Market Move | "The most important stock on earth" NVIDIA Corporation (NVDA.US) is about to announce its second quarter earnings. The stock price rose nearly 1% in intraday trading.

US Stock Market Move | Chip stocks rose slightly, with AMD (AMD.US) up more than 1.3%.

US Stock Market Move | Femasys (FEMY.US) stock price plummets 37%, hitting a new low for the year.

RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025